Clinical Trial Update: Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating the effectiveness of an amlodipine-atorvastatin combination for hypertension and hyperlipidemia; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Amlodipine/atorvastatin combination

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Hyperlipidemia | Phase 4 | Status: COMPLETED